BioLineRx
BLRX
$0.62
Share price
-4.34%
Change (1 day)
-55.30%
Change (1 year)
Categories
BioLineRx (BLRX) - Cash on Hand
Cash on Hand as of December 2023 : $42.99 M
According to BioLineRx's latest financial reports the company has $42.99 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BioLineRx - Cash on Hand chart (from 2011 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $51.08 M | -10.59% |
| 2021-12-31 | $57.13 M | 152.96% |
| 2020-12-31 | $22.58 M | -17.83% |
| 2019-12-31 | $27.48 M | -8.83% |
| 2018-12-31 | $30.15 M | -39.07% |
| 2017-12-31 | $49.48 M | 38.91% |
| 2016-12-31 | $35.62 M | -25.26% |
| 2015-12-31 | $47.66 M | 37.44% |
| 2014-12-31 | $34.68 M | 90.36% |
| 2013-12-31 | $18.21 M | -14.71% |
| 2012-12-31 | $21.35 M | -17.75% |
| 2011-12-31 | $25.97 M |